Endovia Health Sciences (EDVA) Interest Expenses (2012 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Interest Expenses (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.59 Bn | 133.74 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.99 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.39 Bn | 35.29 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.51 Bn | 32.20 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.07 Bn | 27.24 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Endovia Health Sciences | 800,859.67 | 558,157.67 | - | 231,020.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 231,020.00 |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 940,855.00 |
| Sep 30, 2025 | 320,013.00 |
| Jun 30, 2025 | 6.86 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 890,471.00 |
| Jun 30, 2024 | 622,063.00 |
| Mar 31, 2024 | 532,599.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 221,488.00 |
| Jun 30, 2023 | 172,641.00 |
| Mar 31, 2023 | 167,121.00 |
| Dec 31, 2022 | 25,954.00 |
| Sep 30, 2022 | 66,193.00 |
| Jun 30, 2022 | 73,471.00 |
| Mar 31, 2022 | 85,879.00 |
| Dec 31, 2021 | 101,092.00 |
| Sep 30, 2021 | 100,128.00 |